Powered Intracapsular Tonsillotomy and Adenoidectomy in Infants 36 Months Compared to Older Children: A

Avishai Stahl1,2, Or Dagan1, Benny Nageris1,2

  • 1Department of Otorhinolaryngology - Head and Neck Surgery, Meir Medical Center, Kfar Saba, Israel.

Insights

Powered intracapsular tonsillotomy and adenoidectomy (PITA) is safe and effective for infants under 36 months with sleep disordered breathing. Outcomes and safety are comparable to older children, demonstrating PITA

Area of Science:

  • Otolaryngology
  • Pediatric Sleep Medicine
  • Surgical Outcomes Research

Background:

  • Sleep disordered breathing (SDB) significantly impacts child development and quality of life.
  • Surgical interventions like tonsillotomy and adenoidectomy are common treatments for pediatric SDB.
  • Evaluating the safety and efficacy of PITA in younger populations is crucial for expanding treatment options.

Purpose of the Study:

  • To assess the safety and outcomes of powered intracapsular tonsillotomy and adenoidectomy (PITA) in infants up to 36 months of age.
  • To compare PITA outcomes in infants with those in older children (36-72 months).
  • To determine if age influences the short- and long-term results of PITA for SDB.

Main Methods:

  • Retrospective analysis of children undergoing PITA between 2013-2019 at a single tertiary care center.
  • Patients divided into two groups: infants (≤36 months) and older children (36-72 months).
  • Data collected via electronic medical records and a modified OSA-18 questionnaire telephone survey; post-operative complications and outcomes were compared.

Main Results:

  • No significant differences in subjective outcomes were observed between the infant and older child groups (P=0.65).
  • The frequency of post-operative complications did not differ significantly between the age groups (P=0.8).
  • Hospitalization durations were comparable across both age cohorts (P=0.91).

Conclusions:

  • PITA demonstrates similar short- and long-term safety and efficacy for treating sleep disordered breathing in infants up to 36 months compared to older children.
  • The findings support PITA as a viable treatment option for SDB across a broad pediatric age range.
  • Age is not a significant factor in the outcomes or complication rates following PITA for SDB.
Abstract